Skip to main navigation
Skip to main content
Skip to Footer
English
Français
Canada
Répertoire du site Sandoz
Our Work
What We Do
Quality Generics
Biopharmaceuticals
Specialty Products
About Us
Who We Are
Corporate Responsibility
Doing Business Responsibly
Contact Us
Grants, Donations and Sponsorships
Products
Consumers
Patients
Healthcare Professionals
Patient Support Programs
News
Media Releases
Media Resource Center
Stay Up-To-Date
Careers
Available Positions
Diversity & Inclusion
Our Benefits
Sandoz-Connect Portal
Search
All News
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Media Releases
Filter By
2015
October
Media Release
/
Oct 07, 2015
Sandoz Canada launches PrSandoz® Solifenacin on the Canadian market for the treatment of urinary urgency, frequency and incontinence
Read More
September
Media Release
/
Sep 23, 2015
Sandoz Canada Celebrates Its 10th Anniversary!
Read More
Media Release
/
Sep 01, 2015
Health Canada Approves New Indications for PrOmnitrope®, Canada’s First Biosimilar
Read More
August
Media Release
/
Aug 20, 2015
Sandoz Canada launches Pr Amiodarone Syringe for the treatment of several heart rhythm disorders
Read More
Media Release
/
Aug 12, 2015
Sandoz advances its biosimilars program with European Medicines Agency (EMA) acceptance of regulatory submission for biosimilar etanercept
Read More
July
Media Release
/
Jul 30, 2015
Important Safety Information for Repaglinide and clopidogrel. New Contraindication for Concomitant Use
Read More
May
Media Release
/
May 05, 2015
Sandoz wins an award for its social engagement
Read More
February
Media Release
/
Feb 12, 2015
Sandoz Canada Launches a New Concentration of T/CLorazepam Injection USP
Read More
Media Release
/
Feb 10, 2015
FDA accepts Sandoz regulatory submission for a proposed biosimilar etanercept
Read More
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
LinkedIn
Email
Jump to Comments
You are here
Home
›
